Trade with Eva: Analytics in action >>
Showing posts with label BUD. Show all posts
Showing posts with label BUD. Show all posts

Friday, October 25, 2019

Anheuser-Busch InBev (BUD) reported earnings on Fri 25 Oct 19 (b/o)

** charts before earnings **



 




** charts after earnings **








Anheuser-Busch InBev misses by $0.04, misses on revs


  • Reports Q3 (Sep) earnings of $1.22 per share, $0.04 worse than the S&P Capital IQ Consensus of $1.26; revenues fell 0.8% year/year to $13.17 bln vs the $13.78 bln S&P Capital IQ Consensus.
  • Outlook:
    • Overall Performance: "In FY19, we continue to expect to deliver strong revenue growth, driven by the solid performance of our brand portfolio and strong commercial plans. In markets with softer macroeconomic conditions, we are accelerating our smart affordability efforts with initiatives that have lower revenue per hl but offer incremental profit. As a result, FY19 revenue per hl growth should now be slightly below inflation. We continue to expect a more balanced top-line growth between volumes and revenue per hl and for our total costs (sum of CoS per hl and SG&A) to grow below inflation. Overall, we remain confident in our strategy and the fundamental strength of our business, though we now expect moderate EBITDA growth in FY19 given the additional headwinds faced in 3Q19 which we anticipate will continue into 4Q19."
  • Thursday, February 25, 2016

    Anheuser-Busch InBev (BUD) reported earnings on Thur 25 Feb 2016 (b/o)

    ** charts after earnings **



     




    Anheuser-Busch InBev misses by $0.05, misses on revs :
    • Reports Q4 (Dec) earnings of $1.56 per share, excluding non-recurring items,$0.05 worse than the Capital IQ Consensus of $1.61; revenues fell 10.8% year/year to $10.72 bln vs the $11.08 bln Capital IQ Consensus. 
    • Total volumes declined by 0.7%, with own beer volumes up 0.2% and non-beer volumes down 6.5%.
    • Continue to expect the SABMiller (SBMRY) transaction to close in the second half of 2016, subject to regulatory clearances, shareholder approvals and other terms and conditions